Back to Browse Journals » International Journal of Women's Health » Volume 3

Treatment options for polycystic ovary syndrome

Authors Ahmed Badawy, Abubaker Elnashar

Published Date February 2011 Volume 2011:3 Pages 25—35


Published 8 February 2011

Ahmed Badawy1 Abubaker Elnashar2
1Department of Obstetrics and Gynecology, Mansoura University, Mansoura, Egypt; 2Department of Obstetrics and Gynecology, Benha University, Benha, Egypt

Abstract: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women. The clinical manifestation of PCOS varies from a mild menstrual disorder to severe disturbance of reproductive and metabolic functions. Management of women with PCOS depends on the symptoms. These could be ovulatory dysfunction-related infertility, menstrual disorders, or androgen-related symptoms. Weight loss improves the endocrine profile and increases the likelihood of ovulation and pregnancy. Normalization of menstrual cycles and ovulation could occur with modest weight loss as little as 5% of the initial weight. The treatment of obesity includes modifications in lifestyle (diet and exercise) and medical and surgical treatment. In PCOS, anovulation relates to low follicle-stimulating hormone concentrations and the arrest of antral follicle growth in the final stages of maturation. This can be treated with medications such as clomiphene citrate, tamoxifen, aromatase inhibitors, metformin, glucocorticoids, or gonadotropins or surgically by laparoscopic ovarian drilling. In vitro fertilization will remain the last option to achieve pregnancy when others fail. Chronic anovulation over a long period of time is also associated with an increased risk of endometrial hyperplasia and carcinoma, which should be seriously investigated and treated. There are androgenic symptoms that will vary from patient to patient, such as hirsutism, acne, and/or alopecia. These are troublesome presentations to the patients and require adequate treatment. Alternative medicine has been emerging as one of the commonly practiced medicines for different health problems, including PCOS. This review underlines the contribution to the treatment of different symptoms.

Keywords: treatment, polycystic ovary syndrome

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at:

Readers of this article also read:

Gonorrhea infection in women: prevalence, effects, screening, and management

Walker CK, Sweet RL

International Journal of Women's Health 2011, 3:197-206

Published Date: 19 July 2011

Treatment of post-partum depression: a review of clinical, psychological and pharmacological options

Elizabeth Fitelson, Sarah Kim, Allison Scott Baker, et al

International Journal of Women's Health 2011, 3:1-14

Published Date: 30 December 2010

Management of hypoactive sexual desire disorder in women: current and emerging therapies

Rossella E Nappi, Ellis Martini, Erica Terreno, et al

International Journal of Women's Health 2010, 2:167-175

Published Date: 1 July 2010

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors

Eduardo Pimenta, Suzanne Oparil

Vascular Health and Risk Management 2009, 5:453-463

Published Date: 19 May 2009

Current trends in the treatment of polycystic ovary syndrome with desire for children

Margalida E Sastre, Maria O Prat, Miguel Angel Checa, Ramon C Carreras

Therapeutics and Clinical Risk Management 2009, 5:353-360

Published Date: 8 May 2009

Polycystic ovary syndrome and its impact on women’s quality of life: More than just an endocrine disorder

Christine Brady, Shaymaa S Mousa, Shaker A Mousa

Drug, Healthcare and Patient Safety 2009, 1:9-15

Published Date: 3 February 2009